About Rapid Diagnostics
Rapid Diagnostics is a company based in Delhi (India) founded in 1995 by Bharat Jindal. Rapid Diagnostics has raised $2.91 million across 4 funding rounds from investors including Deep Laboratories, Onkarlaboratories and Karwa Enterprise. The company has 94 employees as of April 06, 2024. Rapid Diagnostics offers products and services including In-Vitro Diagnostics, Critical Care Monitoring, and Personal Healthcare.
- Headquarter Delhi, India
- Employees 94 as on 06 Apr, 2024
- Founders Bharat Jindal
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rapid Diagnostic Pvt. Ltd.
- Jurisdiction Delhi, India
-
Annual Revenue
$11.98 M (USD)-12.19as on Mar 31, 2023
-
Net Profit
$1.78 M (USD)23.26as on Mar 31, 2023
-
EBITDA
$2.28 M (USD)9.02as on Mar 31, 2023
-
Total Equity Funding
$2.91 M (USD)
in 4 rounds
-
Latest Funding Round
$1.18 M (USD), Unspecified
Mar 31, 2014
-
Investors
Deep Laboratories
& 6 more
-
Employee Count
94
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rapid Diagnostics
Rapid Diagnostics offers a comprehensive portfolio of products and services, including In-Vitro Diagnostics, Critical Care Monitoring, and Personal Healthcare.
Provides accurate tests for medical diagnostics and reliable results.
Offers advanced monitoring for critical patient care and support.
Delivers comprehensive products for individual health and well-being.
Funding Insights of Rapid Diagnostics
Rapid Diagnostics has successfully raised a total of $2.91M across 4 strategic funding rounds. The most recent funding activity was a Unspecified round of $1.18 million completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Rapid Diagnostics
Rapid Diagnostics has secured backing from 7 investors, including institutional and angel investors. Prominent investors backing the company include Deep Laboratories, Onkarlaboratories and Karwa Enterprise.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Rapid Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rapid Diagnostics
Investment portfolio details for Rapid Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rapid Diagnostics
Detailed financials for Rapid Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rapid Diagnostics Comparisons
Peer comparison for Rapid Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rapid Diagnostics
Detailed competitors of Rapid Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rapid Diagnostics
Complete news archive for Rapid Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rapid Diagnostics
Rapid Diagnostics was founded in 1995 and raised its 1st funding round 12 years after it was founded.
Rapid Diagnostics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Rapid Diagnostics is a funded company, having raised a total of $2.91M across 4 funding rounds to date.
As of Apr 06, 2024, the latest employee count at Rapid Diagnostics is 94.
Annual revenue of Rapid Diagnostics is $11.98M as on Mar 31, 2023.
Rapid Diagnostics is an Indian group of companies engaged in the development and manufacture of a wide range of IVD analyzers, POC diagnostic devices and monitoring equipment for critical care. The companys portfolio includes analyzers for biochemical assays, haematology, coagulation assays, urinalysis, electrolyte analysis, HbA1c analyzers, rapid tests, POC glucometers, POC and hand-held haemoglobinometers, BP instruments, and related consumables and kits. In their critical care portfolio are included multi-parameter patient monitoring systems, EGC machines, fetal Doppler monitors, pulse oximeters, defibrillators, ventilators, oxygen concentrators, and sleep apnoea therapy devices.
Rapid Diagnostics offers In-Vitro Diagnostics, Critical Care Monitoring, and Personal Healthcare.
Rapid Diagnostics has 7 investors. Key investors include Deep Laboratories, Onkarlaboratories, Karwa Enterprise, Aspen Laboratories, and Jagat Diagnostic.
The valuation of Rapid Diagnostics is $5.24M as of Mar 2014.